Evaluation of histopathologic and immunohistochemical features of gastrointestinal stromal tumors
PDF
Cite
Share
Request
Original Article
VOLUME: 22 ISSUE: 1
P: 7 - 12
March 2006

Evaluation of histopathologic and immunohistochemical features of gastrointestinal stromal tumors

Turk J Surg 2006;22(1):7-12
1. Cumhuyiret Üniversitesi Tıp Fakültesi Patoloji AD, SİVAS
No information available.
No information available
PDF
Cite
Share
Request

Abstract

Purpose: To determine the importance of immunohistochemical panel including CD117 in the differential diagnosis of gastrointestinal mesenchymal tumors Introduction: Gastrointestinal stromal tumors are rare mesenchymal tumors of the gut wall. The most important features of these tumors are the expression of CD117 and CD34. There are difficulties in their differential diagnosis with other mesenchymal tumors. In this contexte immunohistochemical panel including CD117, CD34,actin and desmin should be utilized. The variability of their biological behaviour and their eventual curability, increase the importance of these tumors. Material and Methods: In this study mesenchymal tumors of the gastrointestinal tract diagnosed in the Pathology Department of Cumhuriyet University Faculty of Medicine were revised. The immunohistochemical panel necessary for the diagnosis of stromal tumors was applied to all of these cases, to find the rate of occurrence of stromal tumors. Results: Six tumors previously diagnosed as mesenchymal tumor and 11 cases diagnosed as stromal tumor were positive for CD117. After CD117 staining 17 tumors among 20 were diagnosed as stromal tumors Conclusion: CD117 and CD34 are important markers and it seems that by performing immunohistostaining to all mesenchymal tumors, stromal tumors will be diagnosed more frequently.

Keywords:
Gastrointestinal stromal tumors, CD117, CD34

References

1
Goldblum JR. Nonepithelial neoplasms of the GI tract. In Odze R, Goldblum JR, Crawford JM eds.Surgical Pathology of the GI Tract, Liver,Biliary Tract and Pancreas. Philedelphia WB Saunders, 2004:506-516.
2
Yamaguchi U, Hasegawa T, Masuda T, et al. Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows, Arch 2004; 445: 142-150.
3
Robinson TL,Sircar K, Hewlett BR, et al. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of cajal. Am J Pathol, 2000; 156: 1157-63.
4
Sircar K, Hewlett BR, Huizinga JD, et al. Interstitital cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol, 1999; 23: 377-389.
5
Kim C, Day S, Yeh K. Gastrointestinal stromal tumors: Analysis of clinical and pathologic factors. American Surgeon, 2001; 67: 135-137.
6
Strickland L, Letson D, Carlos A, et al. Gastrointestinal stromal tumors. Cancer Control, 2001; 8: 252-261.
7
Yerci Ö, Gürel S, Balaban A ve ark. Gastrointestinal sistemin mezenkimal tümörleri. Türk J Gastroenerol 1999; 10: 432-437.
8
Nowain A, Bhakta H, Pais S, et al. Gastrointestinal stromal tumors: Clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol, 2005; 20: 818-824.
9
Yantiss RK, Spiro IJ, Compton CC, et al. Gastrointestinal stromal tumor versus intraabdominal fibromatosis of the bowel wall. Am J Surg Pathol, 2000; 24: 947-57.
10
Carrillo R, Candia A, Peralto J, et al. Prognostic significance of DNA ploidy and proliferative index (MIB-1 Index) in gastrointestinal stromal tumors. Hum Pathol, 1997; 28: 160-65.
11
Brown RW, Chirala R. Utility of microwave citrate antigen retrieval in diagnostic immunohistochemistry. Mod Pathol, 1995;8: 515-20
12
Uchida H, Sasaki A, Iwaki K, et al. An extramural gastrointestinal stromal tumor of the duedonum mimicking a pancreatic head tumor. J Hepatobiliary Pancreat Surg, 2005; 12: 324-327.
13
Blay JY, Bonvalot S, Casali P, et al. Consensus meeting for the management of gastrointestinal stromal tumors. Annals Oncol, 2005; 16: 566-578.
14
Nilsson B, Bümming P, Meis Kindblom JM et al. Gastrointestinal stromal tumors: The incidence, prevalance,clinical course and prognostication in the preimatinib mesylate era. Cancer, 2005; 15:821-828.
15
Montgomery E, Torbenson MS, Kaushal M, et al. Beta-catenin immunohistochemistry seperates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis.Am J Surg Pathol, 2002;26:1296-301.
16
Ferchichi L, Kourda N, Zermani R, et al. Extragastrointestinal stromal tumors: a report of 4 cases]. Ann Chir, 2006;131:271-5.